A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals (original) (raw)

Role of Dendritic Cells in Chronic HCV Infection and its Correlation with Interferon and Ribavirin Treatment Outcomes

Ahmad Khalaf

International Journal of Science and Research (IJSR), 2016

View PDFchevron_right

The Dendritic Cell: The Immune System’s Adjuvant–A Strategy To Develop a HCV Vaccine?

Marie Larsson

Gastroenterology, 2006

View PDFchevron_right

AISF position paper on HCV in immunocompromised patients

Simone Parisi

Digestive and Liver Disease

View PDFchevron_right

Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients

Adrian Wildfire

Cell Research, 2004

View PDFchevron_right

Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells

ahmet eken

Journal of Viral Hepatitis, 2009

View PDFchevron_right

Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus

Mandvi Bharadwaj

Journal of Clinical Virology, 2004

View PDFchevron_right

Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4 + T-cell proliferation in patients with hepatitis C virus infection

Antonio Riva

Immunology, 2007

View PDFchevron_right

A review of the current anti-HCV therapy: Are we finally ready for interferon-free regimens

Navdeep Dahiya

International Journal of Nutrition, Pharmacology, Neurological Diseases, 2014

View PDFchevron_right

CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment

tatiana Galperine

The Journal of Infectious Diseases, 2002

View PDFchevron_right

Circulating Plasmacytoid Dendritic Cells in Acutely Infected Patients with Hepatitis C Virus Genotype 4 Are Normal in Number and Phenotype

Mohammed Abdelhamid

The Journal of Infectious Diseases, 2010

View PDFchevron_right

Strategies to manage hepatitis C virus (HCV) disease burden

R. Idilman

Journal of Viral Hepatitis, 2014

View PDFchevron_right

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Ibrahim Altraif

Journal of Viral Hepatitis, 2014

View PDFchevron_right

HCV-specific lymphocyte responses in individuals with positive anti-HCV but negative HCV-RNA

Uluhan Sili

Journal of Clinical Virology, 2015

View PDFchevron_right

Anti-HCV and anti-HDV antibodies in blood donors and selected risk groups

jovan taseski

Transfusion Science, 1993

View PDFchevron_right

HCV coinfection of the HIV-infected patients with discordant CD4+ T-cell response to antiretroviral therapy leads to intense systemic inflammation

Donald Anthony

Doklady Biological Sciences, 2017

View PDFchevron_right

HCV and cancer: a case-control study in a high-endemic area

Anna Crispo

Liver International, 2001

View PDFchevron_right

Immunosuppression for liver transplantation in HCV-infected patients: Mechanism-based principles

John Fung

Liver Transplantation, 2005

View PDFchevron_right

Loading of dendritic cells for immunotherapy

A. Van Nuffel

ISBT Science Series, 2013

View PDFchevron_right

Dendritic cells in infectious disease, hypersensitivity, and autoimmunity

Brenda Gonzalez

International Journal of Interferon, Cytokine and Mediator Research, 2010

View PDFchevron_right

Chronic hepatitis C treatment in näive patients

Jorge R Daruich

Annals of Hepatology, 2010

View PDFchevron_right

HBV Chronic Hepatitis during Chemotherapy - an Immune Controlled Disease

Valeriu Gheorghita

View PDFchevron_right

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients

leticia lima

2008

View PDFchevron_right

Influence of the inflammatory response on treatment of hepatitis C with triple therapy

Aline Márcia Marques Braz

Revista da Sociedade Brasileira de Medicina Tropical, 2018

View PDFchevron_right

Hepatitis C virus infection and lymphoma

Olivier Hermine

Mediterranean Journal of Hematology and Infectious Diseases, 2010

View PDFchevron_right

Transfected human dendritic cells to induce antitumor immunity

Hassan Rahimi

Gene Therapy, 1999

View PDFchevron_right

Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation

Deniz DURALI

Immunobiology, 2014

View PDFchevron_right

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Atika Mansoor

Genetic Vaccines and Therapy, 2011

View PDFchevron_right

Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity

marco rossi

The Journal of Immunology, 2005

View PDFchevron_right

Hepatitis C — Overview and Update in Treatment

abdullah alghamdi

Recent Advances in Liver Diseases and Surgery, 2015

View PDFchevron_right

Antiviral therapy in chronic hepatitis C virus infection

Irina Rusu

2019

View PDFchevron_right

Prevalence of hepatitis C serum antibody in autoimmune diseases

Nancy Agmon-Levin

Journal of Autoimmunity, 2009

View PDFchevron_right

Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion

D. Doherty

Hepatology, 2011

View PDFchevron_right

Evaluation of VCH-759 monotherapy in hepatitis C infection

Eric Lawitz

Journal of Hepatology, 2009

View PDFchevron_right

Management of Chronic Hepatitis C Virus Infection in HIV‐Infected Patients

Maggie Westby

Clinical Infectious Diseases, 2008

View PDFchevron_right

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents

Sebastián Figueroa

Clinical Gastroenterology and Hepatology, 2020

View PDFchevron_right